🔗 Share this article

Texas Attorney General Ken Paxton is filing a lawsuit against the manufacturers of Tylenol, alleging the corporations concealed potential risks that the medication presented to children's neurological development.

The lawsuit arrives thirty days after Former President Trump publicized an unsubstantiated connection between taking Tylenol - also known as acetaminophen - throughout gestation and autism spectrum disorder in offspring.

The attorney general is filing suit against J&J, which formerly manufactured the drug, the only pain reliever recommended for women during pregnancy, and the current manufacturer, which now manufacturers it.

In a statement, he said they "misled consumers by profiting off of suffering and promoting medication without regard for the potential hazards."

The company asserts there is lacking scientific proof linking Tylenol to autism.

"These corporations deceived for years, knowingly endangering numerous people to boost earnings," Paxton, from the Republican party, said.

Kenvue commented that it was "deeply concerned by the spread of false claims on the reliability of acetaminophen and the likely effects that could have on the well-being of US mothers and children."

On its online platform, Kenvue also said it had "regularly reviewed the relevant science and there is no credible data that shows a established connection between consuming acetaminophen and autism."

Associations representing physicians and healthcare providers concur.

The leading OB-GYN organization has stated paracetamol - the primary component in Tylenol - is one of the few options for women during pregnancy to address discomfort and elevated temperature, which can create significant medical dangers if left untreated.

"In over twenty years of research on the consumption of acetaminophen in gestation, no reliable research has definitively established that the use of acetaminophen in any trimester of pregnancy leads to brain development issues in offspring," the organization stated.

This legal action cites recent announcements from the Trump administration in arguing the medication is potentially dangerous.

Last month, the former president caused concern from medical authorities when he instructed pregnant women to "resist strongly" not to use acetaminophen when sick.

The US Food and Drug Administration then released a statement that doctors should think about restricting the use of Tylenol, while also mentioning that "a direct connection" between the medication and autism spectrum disorder in children has not been established.

The Health Department head Robert F Kennedy Jr, who oversees the FDA, had vowed in April to initiate "a massive testing and research effort" that would determine the source of autism spectrum disorder in a limited time.

But specialists advised that identifying a single cause of autism spectrum disorder - thought by researchers to be the outcome of a complex mix of genetic and surrounding conditions - would prove challenging.

Autism is a type of permanent neurological difference and impairment that impacts how people perceive and interact with the environment, and is identified using physician assessments.

In his court filing, Paxton - who supports Trump who is seeking federal office - claims Kenvue and Johnson & Johnson "willfully ignored and sought to suppress the research" around paracetamol and autism.

The lawsuit aims to force the corporations "destroy any commercial messaging" that states acetaminophen is secure for women during pregnancy.

The court case echoes the complaints of a collection of parents of minors with autism and attention deficit hyperactivity disorder who sued the producers of acetaminophen in two years ago.

Judicial authorities rejected the legal action, saying investigations from the plaintiffs' authorities was inconclusive.